Abstract
Gelsolin is an important cytoskeletal protein of platelets and studies have shown a close relationship between gelsolin and cardiovascular disease. However, the role of gelsolin in the development of coronary heart disease (CHD) is unclear. In this study, we record the distribution of gelsolin in human platelets and plasma and its association with different types of CHD. This study included 114 cases, with 33 stable angina pectoris (SAP) cases, 81 acute coronary syndrome (ACS) cases—composed of 39 unstable angina pectoris (UAP) and 42 acute myocardial infarction (AMI) cases, and 31 healthy control participants. Gelsolin concentration in platelet rich plasma (PRP) and platelet poor plasma (PPP), actin filament (F-actin) and Gc-globulin of PPP were determined by enzyme-linked immunoadsorbent assay (ELISA). The fluorescence intensity of CD62p and cytoplasmic calcium ([Ca2+]i) in human platelets measured by flow cytometry. We also used turbidimetry to detect the platelet aggregation rate (PAR). We analyzed the correlation between platelet gelsolin concentration and CD62p or plasma F-actin levels among each different patient group. Compared with the control group, the gelsolin level in PRP of UAP and AMI groups increased significantly (P<0.01), while the gelsolin level in PPP of all the three patient groups decreased markedly (P<0.01), and the CD62p, PAR, [Ca2+]i of platelets, F-actin and Gc-globulin of the UAP and AMI groups increased significantly (P<0.01). Compared with the SAP group, the gelsolin level in PRP, the PAR, [Ca2+]i of platelets and CD62p of other two groups increased significantly (P<0.01), F-actin of the AMI group increased markedly (P<0.01). Platelet cytoskeleton protein dynamics vary among the different types of CHD. Platelet gelsolin levels are markedly increased and accompanied by increased platelet activity, F-actin and [Ca2+]i of ACS patients, while gelsolin levels in PPP are markedly lower. Abnormally increased platelet gelsolin levels show high positive correlation with the level of platelet activity. Therefore, platelet gelsolin might be a novel molecular marker and/or a new potential therapeutic target of anti-platelet therapy of ACS.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Gergely F, Andrea F, Gabriella P, et al. Clinical importance of aspirin and clopidogrel resistance. World J Cardiol, 2010, 2: 171–186
Li X F, Jiang Y R, Wu C F, et al. Study on the correlation between platelet function proteins and symptom complex in coronary heart disease (in Chinese). Mol Cardiol China, 2009, 9: 326–331
Gibbons R J, Chatterjee K, Daley J, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American college of cardiology/American Heart Association task force on practice guidelines (committee on management of patients with chronic stable angina). J Am Coll Cardio, 1999, 33: 2092–2197
Braunwald E, Antman E M, Kupersmith J W, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocaridal infarction-summary article: A report of the American college of cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). J Am Coll Cardio, 2002, 40: 1266–1374
World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA, 1997, 277: 925–926
Zhuang M M, Wen Y X, Liu S L, et al. Determination of the level of cytopplasmic free calcium in human platelets with flow cytometry (in Chinese). J Xi’an Jiaotong Univ (Med Sci), 2005, 26: 508–510
Grynkiewicz G, Poenie M, Tsien R Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem, 1985, 260: 3440–3450
Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr, 2006, 83: 456S–460S
Brydon L, Magid K, Steptoe A. Platelets, coronary heart disease, and stress. Brain Behav Immun, 2006, 20: 113–119
Hsu-Lin S, Berman C L, Furie B C, et al. A platelet membrane protein expressed during platelet activation and secretion: Studies using a monoclonal antibody specific for thrombin-activated platelets. J Biol Chem, 1984, 259: 9121–9126
Michelson A D, Furman M I. Laboratory markers of platelet activation and their clinical significance. Curr Opin Hematol, 1999, 6: 342–348
Furman M I, Benoit S E, Barnard M R, et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol, 1998, 31: 352–358
Ikeda H, Takajo Y, Ichiki K, et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation, 1995, 92: 1693–1696
Shimomura H, Ogawa H, Arai H, et al. Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction. Am J Cardiol, 1998, 81: 397–400
Lichtman J H, Bigger J T Jr, Blumenthal J A, et al. Depression and coronary heart disease. Recommendations for screening, referral, and treatment: A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research. Endorsed by the American Psychiatric Association. Circulation, 2008, 118: 1768–1775
García A. Clinical proteomics in platelet research: Challenges ahead. J Thromb Haemost, 2010, 8: 1784–1785
Kwiatkowski D J, Stossel T P, Orkin S H, et al. Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature, 1986, 323: 455–458
Allen, P G. Actin filament uncapping localizes to ruffling lamellae and rocketing vesicles. Nat Cell Biol, 2003, 5: 972–979
Liu Y, Jiang Y R, Yin H J, et al. Gelsolin and cardiovascular diseases (in Chinese). Mol Cardiol China, 2011, 11: 50–53
Vasconcellos C A, Lind S E. Coordinated inhibition of actin-induced platelet aggregation by plasma gelsolin and vitamin D-binding protein. Blood, 1993, 82: 3648–3657
Haddad J G, Harper K D, Guoth M, et al. Angiopathic consequences of saturating the plasma scavenger system for actin. Proc Natl Acad Sci USA, 1990, 87: 1381–1385
Lee W M, Galbraith R M. The extracellular actin-scavenger system and actin toxicity. N Engl J Med, 1992, 326: 1335–1341
Suhler E, Lin W, Yin H L. Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock and myonecrosis. Crit Care Med, 1997, 25: 594–598
White P, Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metabol, 2000, 11: 320–327
López-Farré A J, Mateos-Cáceres P J, Sacristán D, et al. Relationship between vitamin D binding protein and aspirin resistance in coronary ischemic patients: A proteomic study. J Proteome Res, 2007, 6: 2481–2487
Kato M, Kambe M, Kajiyama G. Increased cytosolic free Mg2+ and Ca2+ in platelets of patients with vasospastic. Am J Physiol, 1998, 274: 548–554
Fujinishi A, Takahara K, Ohba C, et al. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease. Angiology, 1997, 48: 515–521
Li G H, Shi Y, Chen Y, et al. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis. Circ Res, 2009, 104: 896–904
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Liu, Y., Yin, H., Jiang, Y. et al. Correlation between platelet gelsolin levels and different types of coronary heart disease. Chin. Sci. Bull. 57, 631–638 (2012). https://doi.org/10.1007/s11434-011-4926-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-011-4926-9